메뉴 건너뛰기




Volumn 39, Issue 4, 2007, Pages 1237-1240

Changing Treatment Protocol From Azathioprine to Mycophenolate Mofetil: Decrease in Renal Dysfunction, Increase in Infections

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

EID: 34248559645     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.03.006     Document Type: Article
Times cited : (15)

References (26)
  • 1
    • 0036316256 scopus 로고    scopus 로고
    • Hospitalizations for cytomegalovirus disease after renal transplantation in the United States
    • Abbott K.C., Hypolite I.O., Viola R., et al. Hospitalizations for cytomegalovirus disease after renal transplantation in the United States. Ann Epidemiol 12 (2002) 402
    • (2002) Ann Epidemiol , vol.12 , pp. 402
    • Abbott, K.C.1    Hypolite, I.O.2    Viola, R.3
  • 2
    • 0036756210 scopus 로고    scopus 로고
    • Side effects of mycophenolate mofetil versus azathioprine in iranian renal transplant recipients (single-center experience)
    • Hakemi M., Shahebrahimi K., Ganji M.R., et al. Side effects of mycophenolate mofetil versus azathioprine in iranian renal transplant recipients (single-center experience). Transplant Proc 34 (2002) 2091
    • (2002) Transplant Proc , vol.34 , pp. 2091
    • Hakemi, M.1    Shahebrahimi, K.2    Ganji, M.R.3
  • 3
    • 27644540081 scopus 로고    scopus 로고
    • The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation
    • Srinivas T.R., Kaplan B., Schold J.D., et al. The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplantation 80 2 suppl (2005) S211
    • (2005) Transplantation , vol.80 , Issue.2 SUPPL
    • Srinivas, T.R.1    Kaplan, B.2    Schold, J.D.3
  • 4
    • 21844440799 scopus 로고    scopus 로고
    • Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols
    • Attallah N., Goggins M., Nori U., et al. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols. Transplant Proc 37 (2005) 2060
    • (2005) Transplant Proc , vol.37 , pp. 2060
    • Attallah, N.1    Goggins, M.2    Nori, U.3
  • 5
    • 19044379570 scopus 로고    scopus 로고
    • Effect of new immunosuppressive regimens on cost of renal transplant maintenance immunosuppression
    • Gentil M.A., Gonzalez-Roncero F., Cantarell C., et al. Effect of new immunosuppressive regimens on cost of renal transplant maintenance immunosuppression. Transplant Proc 37 (2005) 1441
    • (2005) Transplant Proc , vol.37 , pp. 1441
    • Gentil, M.A.1    Gonzalez-Roncero, F.2    Cantarell, C.3
  • 6
    • 0032963401 scopus 로고    scopus 로고
    • Ten-year cost effectiveness of alternative immunosuppression regimens in cadaveric renal transplantation
    • Schnitzler M.A., Woodward R.S., Lowell J.A., et al. Ten-year cost effectiveness of alternative immunosuppression regimens in cadaveric renal transplantation. Transplant Proc 31 3B suppl (1999) 19S
    • (1999) Transplant Proc , vol.31 , Issue.3 B SUPPL
    • Schnitzler, M.A.1    Woodward, R.S.2    Lowell, J.A.3
  • 7
    • 34248563485 scopus 로고    scopus 로고
    • 6-7: Tue, Oct 31, Available at: http://www.iran-daily.com/1385/2695/html/focus.html
    • Dispute Over Inflation Rate. Iran Daily (2006). http://www.iran-daily.com/1385/2695/html/focus.html 6-7: Tue, Oct 31, Available at: http://www.iran-daily.com/1385/2695/html/focus.html
    • (2006) Dispute Over Inflation Rate. Iran Daily
  • 8
    • 34248565048 scopus 로고    scopus 로고
    • Roshandel D, Rezailashkajani M, Shafaee S, et al: A cost analysis of functional bowel disorders in Iran. Int J Colorectal Dis (in press)
  • 9
    • 0032946534 scopus 로고    scopus 로고
    • Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil
    • Wuthrich R.P., Weinreich T., Ambuhl P.M., et al. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil. Nephrol Dial Transplant 14 (1999) 394
    • (1999) Nephrol Dial Transplant , vol.14 , pp. 394
    • Wuthrich, R.P.1    Weinreich, T.2    Ambuhl, P.M.3
  • 10
    • 0031831893 scopus 로고    scopus 로고
    • Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients
    • Fritsche L., Sperschneider H., Budde K., et al. Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients. Transplant Proc 30 (1998) 1190
    • (1998) Transplant Proc , vol.30 , pp. 1190
    • Fritsche, L.1    Sperschneider, H.2    Budde, K.3
  • 11
    • 0034082485 scopus 로고    scopus 로고
    • The use of mycophenolate mofetil in transplant recipients
    • Mele T.S., and Halloran P.F. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 47 (2000) 215
    • (2000) Immunopharmacology , vol.47 , pp. 215
    • Mele, T.S.1    Halloran, P.F.2
  • 12
    • 85047233807 scopus 로고    scopus 로고
    • Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study
    • Woodroffe R., Yao G.L., Meads C., et al. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. Health Technol Assess 9 (2005) 1
    • (2005) Health Technol Assess , vol.9 , pp. 1
    • Woodroffe, R.1    Yao, G.L.2    Meads, C.3
  • 13
    • 0036216535 scopus 로고    scopus 로고
    • Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression
    • Bernabeu-Wittel M., Naranjo M., Cisneros J.M., et al. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression. Eur J Clin Microbiol Infect Dis 21 (2002) 173
    • (2002) Eur J Clin Microbiol Infect Dis , vol.21 , pp. 173
    • Bernabeu-Wittel, M.1    Naranjo, M.2    Cisneros, J.M.3
  • 14
    • 0038346035 scopus 로고    scopus 로고
    • Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation
    • Schnitzler M.A., Craig K.E., Hardinger K.E., et al. Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation. Nephrol Dial Transplant 18 (2003) 1197
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 1197
    • Schnitzler, M.A.1    Craig, K.E.2    Hardinger, K.E.3
  • 15
    • 15844401967 scopus 로고    scopus 로고
    • Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes
    • David K.M., Morris J.A., Steffen B.J., et al. Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes. Clin Transplant 19 (2005) 279
    • (2005) Clin Transplant , vol.19 , pp. 279
    • David, K.M.1    Morris, J.A.2    Steffen, B.J.3
  • 16
    • 33745261588 scopus 로고    scopus 로고
    • Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial
    • Kobashigawa J.A., Tobis J.M., Mentzer R.M., et al. Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial. Am J Transplant 6 5 Pt 1 (2006) 993
    • (2006) Am J Transplant , vol.6 , Issue.5 PART 1 , pp. 993
    • Kobashigawa, J.A.1    Tobis, J.M.2    Mentzer, R.M.3
  • 17
    • 0036755866 scopus 로고    scopus 로고
    • Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection
    • Miladipour A.H., Ghods A.J., and Nejadgashti H. Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection. Transplant Proc 34 (2002) 2089
    • (2002) Transplant Proc , vol.34 , pp. 2089
    • Miladipour, A.H.1    Ghods, A.J.2    Nejadgashti, H.3
  • 18
    • 0029006409 scopus 로고
    • Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
    • European Mycophenolate Mofetil Cooperative Study Group
    • European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345 (1995) 1321
    • (1995) Lancet , vol.345 , pp. 1321
  • 19
    • 0006986048 scopus 로고    scopus 로고
    • A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric kidney transplantation
    • The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group
    • The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric kidney transplantation. Transplantation 61 (1996) 1029
    • (1996) Transplantation , vol.61 , pp. 1029
  • 20
    • 0031002738 scopus 로고    scopus 로고
    • Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year
    • The U.S. Mycophenolate Mofetil Study Group
    • The U.S. Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. Transplant Proc 29 (1997) 348
    • (1997) Transplant Proc , vol.29 , pp. 348
  • 21
    • 14944366253 scopus 로고    scopus 로고
    • Infectious complications in using mofetil micofenolate in patients with renal allotransplant
    • Prokopenko E.I., Shcherbakova E.O., Vatazin A.V., et al. Infectious complications in using mofetil micofenolate in patients with renal allotransplant. Ter Arkh 77 (2005) 67
    • (2005) Ter Arkh , vol.77 , pp. 67
    • Prokopenko, E.I.1    Shcherbakova, E.O.2    Vatazin, A.V.3
  • 22
    • 0034093791 scopus 로고    scopus 로고
    • The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation
    • Ter Meulen C.G., Wetzels J.F.M., and Hilbrands L.B. The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation. Nephrol Dial Transplant 15 (2000) 711
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 711
    • Ter Meulen, C.G.1    Wetzels, J.F.M.2    Hilbrands, L.B.3
  • 23
    • 0031663952 scopus 로고    scopus 로고
    • Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation?. A case-control study
    • Sarmiento J.M., Munn S.R., Paya C.V., et al. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation?. A case-control study. Clin Transplant 12 (1998) 371
    • (1998) Clin Transplant , vol.12 , pp. 371
    • Sarmiento, J.M.1    Munn, S.R.2    Paya, C.V.3
  • 24
    • 0034911679 scopus 로고    scopus 로고
    • Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction
    • Giral M., Nguyen J.M., Daguin P., et al. Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction. J Am Soc Nephrol 12 (2001) 1758
    • (2001) J Am Soc Nephrol , vol.12 , pp. 1758
    • Giral, M.1    Nguyen, J.M.2    Daguin, P.3
  • 25
    • 0034026538 scopus 로고    scopus 로고
    • Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients
    • Sarmiento J.M., Dockrell D.H., Schwab T.R., et al. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients. Clin Transplant 14 (2000) 136
    • (2000) Clin Transplant , vol.14 , pp. 136
    • Sarmiento, J.M.1    Dockrell, D.H.2    Schwab, T.R.3
  • 26
    • 0036224139 scopus 로고    scopus 로고
    • Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation
    • Munoz M.A., Andres A., Gallego R., et al. Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation. Transplant Proc 34 (2002) 97
    • (2002) Transplant Proc , vol.34 , pp. 97
    • Munoz, M.A.1    Andres, A.2    Gallego, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.